ARCHIVES

Velcade Plus Dexamethasone Provides 20% Response In First-Line Treatment

This article is from The Cancer Letter archive.

Vol. 29 No. 12 | December 29, 2006

Download PDF Visit The Full Archive

Related Articles

Faulty Estimates Led NCI To Overstate Black-White Cancer Disparity In Atlanta

September 20, 2002

NCI Programs: Four Awarded Grants For Chem-Bio Centers; NCI To Commit $20M For Cancer Informatics Infrastructure

October 23, 1998

SWOG Launching New Study Based on Recurrence Test Scores

April 29, 2011

MD Anderson Faculty Slam Leadership, Question Moon Shots, Bemoan Workload

March 29, 2013

Imbruvica Improves PFS, OS In Phase III CLL Study

December 26, 2014

In Brief: James Cancer Hospial Recieves $20M Donation

January 22, 1999